Edit Module

Research Reveals Pet Owner Interest In Generic Drugs



Published:

This year’s six-member team of Babson College MBA candidates developed and implemented a market research project addressing veterinary medicine purchasing behavior. Putney, Inc., a pharmaceutical company and partner in the Babson Consulting Alliance Program (BCAP), sponsored the project.

Research results show that adoption of generics in the veterinary pharmacy strengthens the pet owner-veterinarian relationship.

“I’m impressed by the diligence and level of understanding these students bring to their projects,” says Jean Hoffman, president and CEO of Putney. “The results of their research quantify our message to veterinarians that generic pet medicines improve practice revenues and increase client satisfaction.”

BCAP students surveyed pet owners and veterinarians nationwide to investigate key drivers of veterinary medicine purchasing decisions. Among their findings, 83 percent of pet owners surveyed would be happy if their veterinarian offered them a lower-priced, generic version of their pet’s medicine. The statistic mirrors adoption rates of generics in the human pharmaceutical industry, where 78 percent of prescriptions are filled by a generic. 

 “Putney consistently provides our students with challenging projects and professional direction, amplifying their classroom learning and allowing them to generate industry-relevant results,” says Mark Biddle, Ph.D., John Rehm Director of experiential learning at the F. W. Olin School of Business at Babson College and BCAP advisor. “Putney is a valuable alliance partner.”

<Home>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Vet Caught Harming Patients Returns to Work

Residents of the community protested the return of Mahavir Singh Rekhi, DVM, after he was suspended for choking and punching his patients.

UC Davis to Push for Advanced Disaster Preparedness for Pets, Livestock

The Center for Equine Health at UC Davis says there is "a critical lack of funding and standardization for the animal component of disaster planning."

Zoetis Receives FDA Approval for Heartworm Disease Treatment

DIROBAN uses melarsomine dihydrochloride to treat heartworm disease.

Add your comment:
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module